Recap: TherapeuticsMD Q3 Earnings - TherapeuticsMD (NASDAQ:TXMD)

TherapeuticsMD TXMD reported its Q3 earnings results on Thursday, November 11, 2021 at 08:00 AM.

Here's what investors need to know about the announcement.

TherapeuticsMD their estimated earnings by 10.0%, reporting an EPS of $-0.11 versus an estimate of $-0.1, which did not surprise analysts.

Revenue was up $6,064,000 from the same period last year.

Last quarter the company missed on EPS by $0.0, which was followed by a 3.07% increase in the share price the next day.

Here's a look at TherapeuticsMD's past performance:

Quarter	Q2 2021	Q1 2021	Q4 2020	Q3 2020
EPS Estimate	-0.11	-0.12	-0.10	-0.14
EPS Actual	-0.11	-0.11	-0.15	-0.12
Revenue Estimate	22.11M	19.77M	21.89M	15.33M
Revenue Actual	23.00M	19.87M	22.58M	19.34M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.